MBrace Therapeutics logo

MBrace Therapeutics Funding & Investors

MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets.

mbracetrx.com

Total Amount Raised: $110,000,000

MBrace Therapeutics Funding Rounds

  • Series B

    $85,000,000

    Series B Investors

    Avidity Partners
    Venrock
    Alta Partners
    TPG
    Cowen
  • Series A

    $25,000,000

    Series A Investors

    Venrock
    Alta Partners
Funding info provided by Diffbot.